# Nasal Fentanyl for Patient Controlled Treatment of Pain in Cancer

> **NCT01248611** · PHASE1,PHASE2 · COMPLETED · sponsor: **St. Olavs Hospital** · enrollment: 10 (actual)

## Conditions studied

- Chronic Pain
- Cancer

## Interventions

- **DRUG:** fentanyl

## Key facts

- **NCT ID:** NCT01248611
- **Lead sponsor:** St. Olavs Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-05
- **Final completion:** 2011-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2014-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01248611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01248611, "Nasal Fentanyl for Patient Controlled Treatment of Pain in Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01248611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*